Phase I/II clinical trial of combination of OX40 and HDAC inhibitor in patients with Stage IV NSCLC Read more
The Effects And Mechanisms Of TNF-α/TNFR2 In Regulatory T Cells On Microenvironment And Progression In Gastric Cancer Read more
?A Phase 1/2, Dose Escalation And Expansion Study Of The Safety, Tolerability, And Anti-Tumor Activity Of BND-22 Administered Alone And In Combination With Pembrolizumab Or With Cetuximab In Patients With Advanced Solid Tumors Read more
A Phase 1, Multicenter, Open-Label Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of TAB006, As Monotherapy And In Combination With Toripalimab, In Patients With Previously Treated, Advanced Malignancies Read more
Phase I Study Dose Finding Study To Evaluate Safety, Reactogenicity And Immunogenicity Of CV09040102 RAS G12D Mrna Vaccine In HLA- Selected Patients With Pancreatic Cancer Or Colorectal Cancer Harboring The RAS G12D Mutation Read more
Dose Escalation In Patients With Advanced Solid Tumors, And Expansion In Selected Indications Read more
Prospective Collection Of Donor Tissue And Blood Or Leukapheresis Product From Patients With Solid Tumours To Enable Development Of Methods For The Manufacturing Of Clonal Neoantigen T Cell Products (Cnet) Read more
An Open-Label, Multi-Centre Phase I/Iia Study Evaluating The Safety And Clinical Activity Of Neoantigen Reactive T Cells In Patients With Advanced Non-Small Cell Lung Cancer Read more
